Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation

被引:28
|
作者
Yu, Fengxiang [1 ]
Gong, Ping [1 ]
Hu, Zhuqin [2 ]
Qiu, Yu [1 ]
Cui, Yongyao [1 ]
Gao, Xiaoling [1 ]
Chen, Hongzhuan [1 ]
Li, Juan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China
基金
对外科技合作项目(国际科技项目); 中国国家自然科学基金;
关键词
Cu(II)-A beta complex; Aggregation; Microglia; Reactive oxygen species; Tumor necrosis factor-alpha; Nitric oxide; NF-kappa B; NITRIC-OXIDE SYNTHASE; INFLAMMATORY RESPONSE; HYDROGEN-PEROXIDE; N-ACETYLCYSTEINE; MOUSE MODEL; DISEASE; EXPRESSION; LIPOPOLYSACCHARIDE; PROLIFERATION; NEUROTOXICITY;
D O I
10.1186/s12974-015-0343-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Aggregated forms of amyloid-beta (A beta) peptides are important triggers for microglial activation, which is an important pathological component in the brains of Alzheimer's patients. Cu(II) ions are reported to be coordinated to monomeric A beta, drive A beta aggregation, and potentiate A beta neurotoxicity. Here we investigated whether Cu(II) binding modulates the effect of A beta on microglial activation and the subsequent neurotoxicity. Methods: A beta peptides were incubated with Cu(II) at an equimolar ratio to obtain the Cu(II)-A beta complex. Primary and BV-2 microglial cells were treated with Cu(II)-A beta, A beta, or Cu(II). The tumor necrosis factor-alpha (TNF-alpha) and nitric oxide levels in the media were determined. Extracellular hydrogen peroxide was quantified by a fluorometric assay with Amplex Red. Mitochondrial superoxide was detected by MitoSOX oxidation. Results: Incubation of Cu(II) with A beta confers different chemical properties on the resulting complex. At the subneurotoxic concentrations, Cu(II)-A beta (but not A beta or Cu(II) alone) treatment induced an activating morphological phenotype of microglia and induced the microglial release of TNF-alpha and nitric oxide as well as microglia-mediated neuronal damage. Cu(II)-A beta-triggered microglial activation was blocked by nuclear factor (NF)-kappa B inhibitors and was accompanied with NF-kappa B activation. Moreover, Cu(II)-A beta induced hydrogen peroxide release, which was not affected by NADPH oxidase inhibitors. Mitochondrial superoxide production was increased after Cu(II)-A beta stimulation. N-acetyl-cysteine, a scavenger of reactive oxygen species (ROS), inhibited Cu(II)-A beta-elicited microglial release of TNF-alpha and nitric oxide as well as the microglia-mediated neurotoxic effect. Conclusion: Our observations suggest that Cu(II) enhances the effect of A beta on microglial activation and the subsequent neurotoxicity. The Cu(II)-A beta-triggered microglial activation involves NF-kappa B activation and mitochondrial ROS production.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The Mechanism Underlying Amyloid Polymorphism is Opened for Alzheimer's Disease Amyloid-β Peptide
    Selivanova, Olga M.
    Surin, Alexey K.
    Marchenkov, Victor V.
    Dzhus, Ulyana F.
    Grigorashvili, Elizaveta I.
    Suvorina, Mariya Yu.
    Glyakina, Anna V.
    Dovidchenko, Nikita V.
    Galzitskaya, Oxana V.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 54 (02) : 821 - 830
  • [32] Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation
    Hoyer, Wolfgang
    Gronwall, Caroline
    Jonsson, Andreas
    Stahl, Stefan
    Hard, Torleif
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) : 5099 - 5104
  • [33] Molecular Structure of Cu(II)-Bound Amyloid-β Monomer Implicated in Inhibition of Peptide Self-Assembly in Alzheimer's Disease
    Abelein, Axel
    Ciofi-Baffoni, Simone
    Morman, Cecilia
    Kumar, Rakesh
    Giachetti, Andrea
    Piccioli, Mario
    Biverstal, Henrik
    JACS AU, 2022, 2 (11): : 2571 - 2584
  • [34] Targeting the amyloid-β peptide for the treatment of Alzheimer's disease -: Preface
    Tsai, JY
    CURRENT MEDICINAL CHEMISTRY, 2002, 9 (11)
  • [35] Evaluation of amyloid-β protein as an antimicrobial peptide in Alzheimer's disease
    Hunter, Chris
    Fanni, Adeline
    Brown, Dylan
    Chi, Eva
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [36] Inhibition studies on aggregation and cytotoxicity of Alzheimer's amyloid-β peptide
    Murvai, Nikoletta
    Lin, Yuxi
    Molnar, Tamas
    Kovacs, Attila
    Micsonai, Andras
    Bang, Jeong Kyu
    Lee, Young-Ho
    Kardos, Jozsef
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 350A - 351A
  • [37] Pleomorphic Copper Coordination by Alzheimer's Disease Amyloid-β Peptide
    Drew, Simon C.
    Noble, Christopher J.
    Masters, Colin L.
    Hanson, Graeme R.
    Barnham, Kevin J.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (03) : 1195 - 1207
  • [38] Elucidating preferred structures in dimers of Alzheimer's amyloid-β peptide
    Bradner, Abigail
    Russell, Chelsea
    Lammi, Robin K.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [39] Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease
    Tsoy, Andrey
    Umbayev, Bauyrzhan
    Kassenova, Aliya
    Kaupbayeva, Bibifatima
    Askarova, Sholpan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (20)
  • [40] Amyloid-β-peptide-acetylcholinesterase complexes and Alzheimer's disease
    Inestrosa, NC
    De Ferrari, GV
    Muñoz, FJ
    Reyes, AE
    JOURNAL OF PHYSIOLOGY-LONDON, 2000, 523 : 66S - 67S